Symbols

Symbols

CUE

Cue Biopharma·NASDAQ

--

--(--)

--

--(--)

CUE fundamentals

CUE Q2 2025 Earnings

Cue Biopharma (CUE) released its earnings on Aug 12, 2025: revenue was 2.95M (YoY +11.14%), beat estimates; EPS was -0.09 (YoY +55.00%), beat estimates.

Revenue / YoY

2.95M

+11.14%

EPS / YoY

-0.09

+55.00%

Report date

Aug 12, 2025

4:30 PM on Aug 18, 2025

EPS

Actual		-0.48	-0.41	-0.26	-0.44	-0.37	-0.31	-0.37	-0.29	-0.29	-0.28	-0.25	-0.2	-0.17	-0.13	-0.17	-0.09
Forecast		-0.334	-0.385	-0.422	-0.4025	-0.39	-0.3767	-0.295	-0.2775	-0.305	-0.3	-0.282	-0.28	-0.1825	-0.086	-0.1533	-0.13
Surprise	0.00%	-43.71%	-6.49%	+38.39%	-9.32%	+5.13%	+17.71%	-25.42%	-4.50%	+4.92%	+6.67%	+11.35%	+28.57%	+6.85%	-51.16%	-10.89%	+30.77%

Revenue

Actual

--

900.00K

2.40M

8.25M

1.00M

26.00K

68.00K

151.00K

187.00K

1.38M

1.82M

1.72M

2.66M

3.34M

1.58M

421.00K

2.95M

Forecast

--

1.36M

2.40M

1.14M

3.05M

1.13M

513.50K

103.75K

1.95M

907.50K

966.67K

1.21M

1.29M

1.52M

1.70M

1.27M

2.00M

Surprise

0.00%

-33.73%

0.00%

+624.67%

-67.26%

-97.70%

-86.76%

+45.54%

-90.41%

+52.29%

+88.38%

+41.83%

+106.21%

+119.55%

-7.36%

-66.79%

+47.70%

Earnings Call

You can ask Aime

What were the key takeaways from Cue Biopharma’s earnings call?

What does Cue Biopharma do and what are its main business segments?

Did Cue Biopharma beat or miss consensus estimates last quarter?

What is the revenue and EPS growth rate for Cue Biopharma year over year?

What guidance did Cue Biopharma's management provide for the next earnings period?

What is Cue Biopharma's latest dividend and current dividend yield?

What factors drove the changes in Cue Biopharma's revenue and profit?

What is the market's earnings forecast for Cue Biopharma next quarter?